Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
430 INR | +1.24% | +2.83% | +19.05% |
May. 29 | Solara Active Pharma Sciences Limited Re-Affirms Earnings Guidance for the Fiscal Year 2025 | CI |
May. 29 | Transcript : Solara Active Pharma Sciences Limited, Q4 2024 Earnings Call, May 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.05% | 247M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- SOLARA Stock
- News Solara Active Pharma Sciences Limited
- Solara Active Pharma Sciences Widens Consolidated Loss in Fiscal Q2